Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_assertion type Assertion NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_head.
- NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_assertion description "[We conclude that lenalidomide has the potential to induce sustained hematological and cytogenetic remissions in the poor prognosis MDS subgroup of del(5q31) patients with complex chromosomal anomalies and that this is likely to improve overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_provenance.
- NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_assertion evidence source_evidence_literature NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_provenance.
- NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_assertion SIO_000772 15891887 NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_provenance.
- NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_assertion wasDerivedFrom befree-2016 NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_provenance.
- NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_assertion wasGeneratedBy ECO_0000203 NP494589.RAMFpBr5DmwGja_dOhii0kgRYmc0NG04qsdYze2hx89M8130_provenance.